Logo image of BKNG

BOOKING HOLDINGS INC (BKNG) Stock Fundamental Analysis

NASDAQ:BKNG - Nasdaq - US09857L1089 - Common Stock - Currency: USD

5016.01  +97.88 (+1.99%)

After market: 5016.01 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to BKNG. BKNG was compared to 135 industry peers in the Hotels, Restaurants & Leisure industry. BKNG has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. BKNG shows excellent growth, but is valued quite expensive already. These ratings could make BKNG a good candidate for growth and quality investing.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

BKNG had positive earnings in the past year.
BKNG had a positive operating cash flow in the past year.
BKNG had positive earnings in each of the past 5 years.
In the past 5 years BKNG always reported a positive cash flow from operatings.
BKNG Yearly Net Income VS EBIT VS OCF VS FCFBKNG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B

1.2 Ratios

BKNG has a better Return On Assets (21.23%) than 97.71% of its industry peers.
Looking at the Return On Invested Capital, with a value of 50.00%, BKNG belongs to the top of the industry, outperforming 98.47% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for BKNG is significantly above the industry average of 16.06%.
The last Return On Invested Capital (50.00%) for BKNG is above the 3 year average (39.14%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 21.23%
ROE N/A
ROIC 50%
ROA(3y)16.97%
ROA(5y)11.22%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)39.14%
ROIC(5y)26.17%
BKNG Yearly ROA, ROE, ROICBKNG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 100 -100 -150

1.3 Margins

BKNG has a Profit Margin of 24.78%. This is amongst the best in the industry. BKNG outperforms 97.71% of its industry peers.
BKNG's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 31.97%, BKNG belongs to the best of the industry, outperforming 98.47% of the companies in the same industry.
BKNG's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 31.97%
PM (TTM) 24.78%
GM N/A
OM growth 3Y13.4%
OM growth 5Y-1.21%
PM growth 3Y32.58%
PM growth 5Y-5.16%
GM growth 3YN/A
GM growth 5YN/A
BKNG Yearly Profit, Operating, Gross MarginsBKNG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

7

2. Health

2.1 Basic Checks

BKNG has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
BKNG has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, BKNG has less shares outstanding
BKNG has a worse debt/assets ratio than last year.
BKNG Yearly Shares OutstandingBKNG Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
BKNG Yearly Total Debt VS Total AssetsBKNG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

BKNG has an Altman-Z score of 6.89. This indicates that BKNG is financially healthy and has little risk of bankruptcy at the moment.
BKNG has a Altman-Z score of 6.89. This is amongst the best in the industry. BKNG outperforms 91.60% of its industry peers.
BKNG has a debt to FCF ratio of 2.10. This is a good value and a sign of high solvency as BKNG would need 2.10 years to pay back of all of its debts.
BKNG's Debt to FCF ratio of 2.10 is amongst the best of the industry. BKNG outperforms 85.50% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.1
Altman-Z 6.89
ROIC/WACC5.39
WACC9.27%
BKNG Yearly LT Debt VS Equity VS FCFBKNG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B 10B

2.3 Liquidity

BKNG has a Current Ratio of 1.31. This is a normal value and indicates that BKNG is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.31, BKNG is in the better half of the industry, outperforming 65.65% of the companies in the same industry.
A Quick Ratio of 1.31 indicates that BKNG should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.31, BKNG is doing good in the industry, outperforming 68.70% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
BKNG Yearly Current Assets VS Current LiabilitesBKNG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 22.27% over the past year.
The Earnings Per Share has been growing by 12.66% on average over the past years. This is quite good.
Looking at the last year, BKNG shows a quite strong growth in Revenue. The Revenue has grown by 11.11% in the last year.
Measured over the past years, BKNG shows a quite strong growth in Revenue. The Revenue has been growing by 9.52% on average per year.
EPS 1Y (TTM)22.27%
EPS 3Y60.13%
EPS 5Y12.66%
EPS Q2Q%29.84%
Revenue 1Y (TTM)11.11%
Revenue growth 3Y29.39%
Revenue growth 5Y9.52%
Sales Q2Q%14.36%

3.2 Future

BKNG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 18.76% yearly.
The Revenue is expected to grow by 8.27% on average over the next years. This is quite good.
EPS Next Y12.89%
EPS Next 2Y14.16%
EPS Next 3Y14.86%
EPS Next 5Y18.76%
Revenue Next Year7.73%
Revenue Next 2Y8.26%
Revenue Next 3Y8.51%
Revenue Next 5Y8.27%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
BKNG Yearly Revenue VS EstimatesBKNG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 10B 20B 30B 40B
BKNG Yearly EPS VS EstimatesBKNG Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 100 200 300 400 500

3

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 26.72 indicates a quite expensive valuation of BKNG.
Based on the Price/Earnings ratio, BKNG is valued a bit cheaper than the industry average as 60.31% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 29.43, BKNG is valued at the same level.
BKNG is valuated rather expensively with a Price/Forward Earnings ratio of 23.67.
BKNG's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of BKNG to the average of the S&P500 Index (22.67), we can say BKNG is valued inline with the index average.
Industry RankSector Rank
PE 26.72
Fwd PE 23.67
BKNG Price Earnings VS Forward Price EarningsBKNG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BKNG is valued a bit more expensive than the industry average as 65.65% of the companies are valued more cheaply.
Based on the Price/Free Cash Flow ratio, BKNG is valued a bit cheaper than 76.34% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.03
EV/EBITDA 19.95
BKNG Per share dataBKNG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 200 -200 400 600

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
BKNG has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as BKNG's earnings are expected to grow with 14.86% in the coming years.
PEG (NY)2.07
PEG (5Y)2.11
EPS Next 2Y14.16%
EPS Next 3Y14.86%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.71%, BKNG is not a good candidate for dividend investing.
BKNG's Dividend Yield is a higher than the industry average which is at 3.06.
With a Dividend Yield of 0.71, BKNG pays less dividend than the S&P500 average, which is at 2.28.
Industry RankSector Rank
Dividend Yield 0.71%

5.2 History

BKNG does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
BKNG Yearly Dividends per shareBKNG Yearly Dividends per shareYearly Dividends per share 2024 2025 10 20 30

5.3 Sustainability

BKNG pays out 19.96% of its income as dividend. This is a sustainable payout ratio.
DP19.96%
EPS Next 2Y14.16%
EPS Next 3Y14.86%
BKNG Yearly Income VS Free CF VS DividendBKNG Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B
BKNG Dividend Payout.BKNG Dividend Payout, showing the Payout Ratio.BKNG Dividend Payout.PayoutRetained Earnings

BOOKING HOLDINGS INC

NASDAQ:BKNG (2/28/2025, 9:45:32 PM)

After market: 5016.01 0 (0%)

5016.01

+97.88 (+1.99%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)04-30 2025-04-30/amc
Inst Owners94.14%
Inst Owner Change1.02%
Ins Owners0.14%
Ins Owner Change-0.48%
Market Cap166.03B
Analysts77.33
Price Target5434.72 (8.35%)
Short Float %2.17%
Short Ratio3.01
Dividend
Industry RankSector Rank
Dividend Yield 0.71%
Yearly Dividend34.87
Dividend Growth(5Y)N/A
DP19.96%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-07 2025-03-07 (9.6)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)9.58%
Min EPS beat(2)6.1%
Max EPS beat(2)13.06%
EPS beat(4)4
Avg EPS beat(4)17.03%
Min EPS beat(4)6.1%
Max EPS beat(4)41.9%
EPS beat(8)8
Avg EPS beat(8)14.1%
EPS beat(12)12
Avg EPS beat(12)38.27%
EPS beat(16)15
Avg EPS beat(16)29.7%
Revenue beat(2)2
Avg Revenue beat(2)3.13%
Min Revenue beat(2)2.74%
Max Revenue beat(2)3.52%
Revenue beat(4)3
Avg Revenue beat(4)1.9%
Min Revenue beat(4)-0.41%
Max Revenue beat(4)3.52%
Revenue beat(8)4
Avg Revenue beat(8)1.03%
Revenue beat(12)7
Avg Revenue beat(12)0.97%
Revenue beat(16)10
Avg Revenue beat(16)1.77%
PT rev (1m)2.09%
PT rev (3m)6.35%
EPS NQ rev (1m)-2.41%
EPS NQ rev (3m)-1.52%
EPS NY rev (1m)-0.89%
EPS NY rev (3m)-0.94%
Revenue NQ rev (1m)-1.34%
Revenue NQ rev (3m)-0.87%
Revenue NY rev (1m)-0.59%
Revenue NY rev (3m)-0.89%
Valuation
Industry RankSector Rank
PE 26.72
Fwd PE 23.67
P/S 6.99
P/FCF 21.03
P/OCF 19.95
P/B N/A
P/tB N/A
EV/EBITDA 19.95
EPS(TTM)187.73
EY3.74%
EPS(NY)211.92
Fwd EY4.22%
FCF(TTM)238.49
FCFY4.75%
OCF(TTM)251.45
OCFY5.01%
SpS717.19
BVpS-121.45
TBVpS-247.76
PEG (NY)2.07
PEG (5Y)2.11
Profitability
Industry RankSector Rank
ROA 21.23%
ROE N/A
ROCE 62.92%
ROIC 50%
ROICexc N/A
ROICexgc N/A
OM 31.97%
PM (TTM) 24.78%
GM N/A
FCFM 33.25%
ROA(3y)16.97%
ROA(5y)11.22%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)39.14%
ROIC(5y)26.17%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)49.26%
ROCE(5y)32.93%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y13.4%
OM growth 5Y-1.21%
PM growth 3Y32.58%
PM growth 5Y-5.16%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover0.86
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 2.1
Debt/EBITDA 1.82
Cap/Depr 72.59%
Cap/Sales 1.81%
Interest Coverage 7.96
Cash Conversion 101.75%
Profit Quality 134.21%
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 6.89
F-Score7
WACC9.27%
ROIC/WACC5.39
Cap/Depr(3y)74.21%
Cap/Depr(5y)71.46%
Cap/Sales(3y)1.86%
Cap/Sales(5y)2.51%
Profit Quality(3y)166.56%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)22.27%
EPS 3Y60.13%
EPS 5Y12.66%
EPS Q2Q%29.84%
EPS Next Y12.89%
EPS Next 2Y14.16%
EPS Next 3Y14.86%
EPS Next 5Y18.76%
Revenue 1Y (TTM)11.11%
Revenue growth 3Y29.39%
Revenue growth 5Y9.52%
Sales Q2Q%14.36%
Revenue Next Year7.73%
Revenue Next 2Y8.26%
Revenue Next 3Y8.51%
Revenue Next 5Y8.27%
EBIT growth 1Y29.95%
EBIT growth 3Y46.73%
EBIT growth 5Y8.2%
EBIT Next Year20.7%
EBIT Next 3Y14.34%
EBIT Next 5Y13.97%
FCF growth 1Y12.79%
FCF growth 3Y46.4%
FCF growth 5Y11.91%
OCF growth 1Y13.33%
OCF growth 3Y43.44%
OCF growth 5Y11.34%